Huskens et al., 1997 - Google Patents
Alkaline earth metal and lanthanide (III) complexes of ligands based upon 1, 4, 7, 10-tetraazacyclododecane-1, 7-bis (acetic acid)Huskens et al., 1997
View PDF- Document ID
- 1191061259195319406
- Author
- Huskens J
- Torres D
- Kovacs Z
- André J
- Geraldes C
- Sherry A
- Publication year
- Publication venue
- Inorganic chemistry
External Links
Snippet
The macrocyclic ligand DO2A (1, 4, 7, 10-tetraazacyclododecane-1, 7-bis (acetic acid)) was prepared and used as a building block for four new macrocyclic ligands having mixed side- chain chelating groups. These ligands and their complexes with MgII, CaII, and LnIII were …
- 230000027455 binding 0 title abstract description 183
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/085—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/10—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus organic compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6524—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having four or more nitrogen atoms as the only ring hetero atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0002—General or multifunctional contrast agents, e.g. chelated agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K8/00—Cosmetic or similar toilet preparations
- A61K8/18—Cosmetic or similar toilet preparations characterised by the composition
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Huskens et al. | Alkaline earth metal and lanthanide (III) complexes of ligands based upon 1, 4, 7, 10-tetraazacyclododecane-1, 7-bis (acetic acid) | |
| Clough et al. | Ligand design strategies to increase stability of gadolinium-based magnetic resonance imaging contrast agents | |
| Woods et al. | Correlation of water exchange rate with isomeric composition in diastereoisomeric gadolinium complexes of tetra (carboxyethyl) dota and related macrocyclic ligands | |
| Kotek et al. | Lanthanide (III) complexes of novel mixed carboxylic‐phosphorus acid derivatives of diethylenetriamine: a step towards more efficient MRI contrast agents | |
| Kálmán et al. | Synthesis, potentiometric, kinetic, and NMR Studies of 1, 4, 7, 10-tetraazacyclododecane-1, 7-bis (acetic acid)-4, 10-bis (methylenephosphonic acid)(DO2A2P) and its complexes with Ca (II), Cu (II), Zn (II) and lanthanide (III) ions | |
| Parker et al. | Being excited by lanthanide coordination complexes: aqua species, chirality, excited-state chemistry, and exchange dynamics | |
| Kubíček et al. | A bisphosphonate monoamide analogue of DOTA: a potential agent for bone targeting | |
| Werner et al. | High‐relaxivity MRI contrast agents: where coordination chemistry meets medical imaging | |
| Tircsó et al. | Equilibrium and formation/dissociation kinetics of some LnIIIPCTA complexes | |
| Aime et al. | Synthesis and NMR studies of three pyridine-containing triaza macrocyclic triacetate ligands and their complexes with lanthanide ions | |
| Brücher et al. | Stability and toxicity of contrast agents | |
| Aime et al. | NMR, relaxometric, and structural studies of the hydration and exchange dynamics of cationic lanthanide complexes of macrocyclic tetraamide ligands | |
| Vojtíšek et al. | Crystal structures of lanthanide (III) complexes with cyclen derivative bearing three acetate and one methylphosphonate pendants | |
| Vitha et al. | Lanthanide (III) complexes of bis (phosphonate) monoamide analogues of DOTA: bone-seeking agents for imaging and therapy | |
| Jang et al. | Mechanism and energetics for complexation of 90Y with 1, 4, 7, 10-tetraazacyclododecane-1, 4, 7, 10-tetraacetic acid (DOTA), a model for cancer radioimmunotherapy | |
| Hajela et al. | A tris-hydroxymethyl-substituted derivative of Gd-TREN-Me-3, 2-HOPO: an MRI relaxation agent with improved efficiency | |
| Regueiro-Figueroa et al. | Toward the prediction of water exchange rates in magnetic resonance imaging contrast agents: a density functional theory study | |
| Le Fur et al. | Expanding the family of pyclen-based ligands bearing pendant picolinate arms for lanthanide complexation | |
| Pierre et al. | Contrast agents for MRI: experimental methods | |
| Balogh et al. | Pyridine-and phosphonate-containing ligands for stable Ln complexation. Extremely fast water exchange on the GdIII chelates | |
| Zhang et al. | 1H and 17O NMR detection of a lanthanide-bound water molecule at ambient temperatures in pure water as solvent | |
| Abozeid et al. | Inner-sphere and outer-sphere water interactions in Co (II) paraCEST agents | |
| Bretonnière et al. | Solid-state and solution properties of the lanthanide complexes of a new heptadentate tripodal ligand: A route to gadolinium complexes with an improved relaxation efficiency | |
| Tircsó et al. | (S)-5-(p-nitrobenzyl)-PCTA, a promising bifunctional ligand with advantageous metal ion complexation kinetics | |
| Hedinger et al. | Trinuclear Lanthanoid Complexes of 1, 3, 5-Triamino-1, 3, 5-trideoxy-cis-inositol with a Unique, Sandwich-Type Cage Structure1 |